MitchellSmithDOMS

Allergy & Immunology • Greenwood, IN

Physician/Shareholder - Allergy Partners

Join to view full profile

Dr. Smith is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Smith's full profile

Already have an account?

Office
965 Emerson Pkwy
Ste B
Greenwood, IN 46143
Phone+1 317-865-0055

Fax+1 317-865-0056

Education & Training

Henry Ford Health/Henry Ford HospitalFellowship, Allergy and Immunology, 2013 - 2015
Ascension St Vincent Hospital IndianapolisResidency, Internal Medicine, 2010 - 2013
Lake Erie College of Osteopathic Medicine Bradenton CampusClass of 2010

Certifications & Licensure

IN State License 2013 - 2025
MI State License 2013 - 2015
American Board of Allergy and Immunology Allergy & Immunology
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Indianapolis Top Doctor - Allergy/Immunology Indianapolis Monthly, 2022-2023

Clinical Trials

Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact Dermatitis Start of enrollment: 2019 Oct 15
Active, not recruiting
Phase 2
A Study to Evaluate the Safety and Efficacy of SB206 in Subjects With Molluscum Contagiosum Start of enrollment: 2018 Jan 24
Completed
Phase 2
Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo Start of enrollment: 2021 Mar 04
Terminated
Phase 2
A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 Antihistamines Start of enrollment: 2021 Nov 30
Completed
Phase 3
An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib Start of enrollment: 2022 Dec 09
Recruiting
Phase 3
A Study to Assess Subcutaneous Lirentelimab (AK002) in Chronic Spontaneous Urticaria Start of enrollment: 2022 Oct 26
Terminated
Phase 2
Join now to see all

Publications & Presentations

Lectures

Anaphylaxis
Indiana Osteopathic Association Spring Update - 5/2021
Updates in Food Allergy
Indiana Osteopathic Association Winter Meeting - 12/2020

Professional Memberships

American Academy of Allergy Asthma and Immunology - AAAAI
Fellow
American College of Allergy, Asthma and Immunology - ACAAI
Fellow
Indiana Allergy Society
Member
Indiana Osteopathic Association
Member

External Links

Practice websitehttps://www.allergypartners.com/find-a-location/indiana/greenwood/